KeyBanc lowers Fiserv stock price target to $200 on growth concerns

Fiserv (FI) has seen its stock decline over 15% in the past week, as multiple analyst firms, including KeyBanc, TD Cowen, and RBC Capital, lowered price targets despite the company exceeding Q2 2025 earnings and revenue forecasts. Analysts cited concerns over decelerating organic growth, reduced margin expansion projections, and downward revisions to full-year guidance, creating uncertainty around future targets like the Clover unit's 2026 revenue. This cautious outlook underscores investor focus on Fiserv's growth trajectory despite its current strong gross profit margin and free cash flow.

Analysis

Fiserv's stock has experienced a significant decline of over 15% in the past week, a move driven by a disconnect between its recent performance and its forward-looking guidance. The company surpassed Q2 2025 expectations, reporting adjusted EPS of $2.47 on revenue of $5.52 billion, beating forecasts of $2.43 and $5.2 billion, respectively. However, this earnings beat was overshadowed by a downward revision of its full-year guidance. Management cited multiple small factors creating a cumulative 1% headwind to organic growth projections and pointed to merger integration costs and higher sales expenditures as reasons for reduced margin expansion. This has led to broad-based price target reductions from analysts at KeyBanc, TD Cowen, and RBC Capital, among others. The guidance revision has cast doubt on Fiserv's ability to achieve its 2026 targets, including the critical $4.5 billion revenue goal for its Clover payment platform. Despite the cautious outlook, the company's fundamentals remain robust, with a 61% gross profit margin and $5.2 billion in free cash flow over the last twelve months, and its increased share repurchase activity is viewed as a positive signal by some analysts who have maintained an Overweight rating.

Key Decisions for Investors

• Investors should weigh the company's strong current fundamentals, including a 61% gross profit margin and significant free cash flow, against the uncertainty created by the downward revision to its full-year growth and margin guidance.
• The performance of the Clover business unit is now a critical focal point; its growth trajectory will be a key indicator of whether the current slowdown is a temporary headwind or a structural issue impacting long-term 2026 targets.
• Given the stock's sharp 15% pullback, the increased share repurchase program could provide some valuation support, but continued scrutiny of organic growth rates in subsequent quarters is warranted before building a significant position.